EN | 中文
NEWS
5
Nov
2021
Cellenkos® Inc. Secures $15 Million Series A Financing to Accelerate the Development of Transformation Cell-Based Therapies
4
Nov
2021
Oculis Announces an Oversubscribed US$57 million Series C Financing
4
Nov
2021
Boan Biotech Completed a New Round of Financing, Accelerating Global Development of Its Biopharmaceutical Business
4
Sept
2021
Acuvu Completed 100 Million RMB in Series B Financing to Promote Innovation in Disposable Endoscope Products and Accelerate Global Distribution
30
Aug
2021
Biocytogen Submitted Form to Hong Kong Stock Exchange for IPO Application
22
Jun
2021
Biocytogen Announced Completion of New Round of Financing of Multi-Dozen Millions of Dollars to Build R&D Engine for Antibody Drugs
19
Jun
2021
CARsgen Therapeutics officially listing on HKEX
21
May
2021
Allgen Listed on STAR Market, Stock Price Surging over 472%
9
Feb
2021
Drug Farm Closes $56M USD Financing for Advancement of Lead Hepatitis B Drug into Clinical Trials
15
Jan
2021
Yidu Technology Listed on the Hong Kong Stock Exchange
2
Nov
2020
CARsgen Therapeutics Closes a USD 186 Million Series C Equity Financing to Accelerate Global Clinical Trials of its Cell Therapy Product Candidates
22
Sept
2020
Ruibo Completed C+ Round of Financing of 250 Million RMB
15
Sept
2020
Biocytogen Announced the Completion of 970 Million RMB in D+ Round of Financing
12
Aug
2020
Cathay Biotech Inc.(688065.SH) officially listed on the STAR Market
5
Aug
2020
MicuRx Closes nearly $43M series D financing to accelerate the preparation of commercialization
9
May
2020
Novast Completed Nearly One Billion RMB Private Equity Financing
3
Apr
2020
Ruibo Biotech Secured 470 million RMB in C2 Round of Financing